Mobile Van Launches Advanced Lung Cancer Screenings in NYC

A new health initiative has launched in New York City, aimed at providing advanced lung cancer screenings directly to individuals at heightened risk. A mobile screening van, equipped with cutting-edge imaging technology, began operations this month as part of a collaboration involving Weill Cornell Imaging at NewYork-Presbyterian, the Herbert Irving Comprehensive Cancer Center at Columbia University Irving Medical Center, and the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine.

This initiative seeks to address the significant gap in lung cancer screenings, particularly among those who may not have easy access to healthcare facilities. Lung cancer remains the leading cause of cancer-related deaths in the United States, with an estimated 227,000 individuals expected to be diagnosed in 2025. Notably, only 19% of eligible New Yorkers currently receive the recommended screenings, which utilize low-dose CT scans to detect the disease early, even before symptoms appear.

The mobile van, a 40-foot vehicle weighing 44,000 pounds, will travel across the five boroughs of New York City, strategically targeting areas where it is most convenient for patients to access screenings. In addition to lung cancer detection, the program offers care navigation, tobacco cessation support, and seamless referrals for follow-up care.

Dr. Bradley Pua, program director and associate professor of radiology at Weill Cornell Medicine, emphasized the importance of this initiative. “Our goal is to break down the systemic and logistical barriers that keep patients from receiving timely, high-quality care,” he stated. “We’re taking the scanner to the streets—directly to the people who need it most.”

Dr. A. Phoenix Matthews, professor of behavioral sciences at Columbia University School of Nursing, echoed this sentiment, noting that addressing the lung cancer burden in communities is a top priority. “We are dedicated to improving the health of all New York City residents by providing access to high-quality screening, especially in resource-limited areas,” he said.

Screening Details and Accessibility

The mobile van will be officially launched with a ribbon-cutting ceremony on October 17, 2023, at Weill Cornell Medicine. It will be stationed near community-based Federally Qualified Health Centers and other neighborhoods identified through data on lung cancer incidence, mortality, and smoking rates.

Patients who visit the van will receive personalized care, including follow-up guidance not only for lung nodules but also for any incidental findings, such as coronary calcium. Eligibility for low-dose CT screening includes individuals aged 50-80 (or 50-77 for Medicare), current or former smokers who quit within the last 15 years, and those with a minimum of 20 pack-years of smoking history. A pack-year is defined as smoking one pack, or about 20 cigarettes, per day for a year.

Screenings and consultations are typically fully covered by commercial insurance, Medicare, and Medicaid, ensuring that there is no cost sharing for the patients. To schedule a telehealth consultation, individuals can call 646-962-LUNG (5864) or visit the program’s website for more information and to see a list of upcoming mobile screening locations.

This initiative represents a proactive step towards improving lung cancer detection and ultimately saving lives in New York City. By bringing advanced screening technology directly to the communities that need it most, the program aims to foster a healthier future for all residents.